Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas

References

• Giordano TJ. Genomic hallmarks of thyroid neoplasia. Annu Rev Pathol. 2018;13:141–162. doi:10.1146/annurev-pathol-121808-10213929083981
   PubMed Web of Science ®Google Scholar
• Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. J Surg Oncol. 2015;112(2):149–154. doi:10.1002/jso.2396726175314
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.002026462967
   PubMed Web of Science ®Google Scholar
• Kim H, Kim TH, Choe JH, et al. Patterns of initial recurrence in completely resected papillary thyroid carcinoma. Thyroid. 2017;27(7):908–914. doi:10.1089/thy.2016.064828446060
   PubMed Web of Science ®Google Scholar
• Pyo JS, Sohn JH, Chang K. Prognostic role of metastatic lymph node ratio in papillary thyroid carcinoma. J Pathol Transl Med. 2018;52(5):331–338. doi:10.4132/jptm.2018.08.0730157618
   PubMed Web of Science ®Google Scholar
• Adam MA, Pura J, Goffredo P, et al. Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol. 2015;33(21):2370–2375. doi:10.1200/JCO.2014.59.839126077238
   PubMed Web of Science ®Google Scholar
• Feng JW, Qin AC, Ye J, Pan H, Jiang Y, Qu Z. Predictive factors for lateral lymph node metastasis and skip metastasis in papillary thyroid carcinoma. Endocr Pathol. 2020;31(1):67–76. doi:10.1007/s12022-019-09599-w31828583
   PubMed Web of Science ®Google Scholar
• Teixeira G, Teixeira T, Gubert F, Chikota H, Tufano R. The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery. 2011;150(6):1161–1167. doi:10.1016/j.surg.2011.09.01922136836
   PubMed Web of Science ®Google Scholar
• Feng JW, Yang XH, Wu BQ, Sun DL, Jiang Y, Qu Z. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Clin Transl Oncol. 2019;21(11):1482–1491. doi:10.1007/s12094-019-02076-030879178
   PubMed Web of Science ®Google Scholar
• Roh JL, Park JY, Kim JM, Song CJ. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol. 2009;99(1):28–31. doi:10.1002/jso.2116418942072
   PubMed Web of Science ®Google Scholar
• Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92(9):3590–3594. doi:10.1210/jc.2007-044417609301
   PubMed Web of Science ®Google Scholar
• Solorzano CC, Carneiro DM, Ramirez M, Lee TM, Irvin GL. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg. 2004;70(7):576–580;discussion 580–572.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Satake H, Sawaki A, Ishigaki T, Funahashi H, Imai T. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol. 1998;29(1):4–10. doi:10.1016/s0720-048x(97)00184-89934552
   PubMed Web of Science ®Google Scholar
• Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. 2019;112:14–21. doi:10.1016/j.ejrad.2019.01.00630777203
   PubMed Web of Science ®Google Scholar
• Saravana-Bawan B, Bajwa A, Paterson J, McMullen T. Active surveillance of low-risk papillary thyroid cancer: a meta-analysis. Surgery. 2020;167(1):46–55. doi:10.1016/j.surg.2019.03.04031526581
   PubMed Web of Science ®Google Scholar
• Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma. Thyroid. 2021;31(2):183–192. doi:10.1089/thy.2020.033033023426
   PubMed Web of Science ®Google Scholar
• Jin WX, Ye DR, Sun YH, et al. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag Res. 2018;10:3237–3243. doi:10.2147/CMAR.S16974130233240
   PubMed Web of Science ®Google Scholar
• Liu C, Xiao C, Chen J, et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019;19(1):622. doi:10.1186/s12885-019-5835-631238891
   PubMed Web of Science ®Google Scholar
• Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018;39(2):e2–e44. doi:10.1055/a-0586-110729510439
   PubMed Web of Science ®Google Scholar
• Hornung M, Jung EM, Georgieva M, Schlitt HJ, Stroszczynski C, Agha A. Detection of microvascularization of thyroid carcinomas using linear high resolution contrast-enhanced ultrasonography (CEUS). Clin Hemorheol Microcirc. 2012;52(2–4):197–203. doi:10.3233/ch-2012-159722975937
   PubMed Web of Science ®Google Scholar
• Wei X, Li Y, Zhang S, Gao M. Prediction of thyroid extracapsular extension with cervical lymph node metastases (ECE-LN) by CEUS and BRAF expression in papillary thyroid carcinoma. Tumour Biol. 2014;35(9):8559–8564. doi:10.1007/s13277-014-2119-224863948
   PubMedGoogle Scholar
• Zhan J, Zhang LH, Yu Q, et al. Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma. Ther Adv Med Oncol. 2020;12:1758835920942367. doi:10.1177/175883592094236732843902
   PubMed Web of Science ®Google Scholar
• Zhan J, Diao X, Chen Y, Wang W, Ding H. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Clin Hemorheol Microcirc. 2019;72(1):61–73. doi:10.3233/CH-18045430452407
   PubMed Web of Science ®Google Scholar
• Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892–899. doi:10.1148/radiol.1111020621771959
   PubMed Web of Science ®Google Scholar
• He Y, Wang XY, Hu Q, Chen XX, Ling B, Wei HM. Value of contrast-enhanced ultrasound and acoustic radiation force impulse imaging for the differential diagnosis of benign and malignant thyroid nodules. Front Pharmacol. 2018;9:1363. doi:10.3389/fphar.2018.0136330542283
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X, Li J, Cai Q, Qiao Z, Luo YK. Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer. Eur Radiol. 2021. doi:10.1007/s00330-020-07516-y
   Web of Science ®Google Scholar
• El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors’ perspectives. Hum Pathol. 2017;66:10–12. doi:10.1016/j.humpath.2017.05.01428583885
   PubMed Web of Science ®Google Scholar
• Bunone G, Vigneri P, Mariani L, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol. 1999;155(6):1967–1976. doi:10.1016/S0002-9440(10)65515-010595926
   PubMed Web of Science ®Google Scholar
• Wang QC, Cheng W, Wen X, Li JB, Jing H, Nie CL. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma. Asian Pac J Cancer Prev. 2014;15(2):855–860. doi:10.7314/apjcp.2014.15.2.85524568507
   PubMedGoogle Scholar
• Tallini G, De Leo A, Repaci A, et al. Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification. Cancers. 2020;12(1):246. doi:10.3390/cancers12010246
   PubMed Web of Science ®Google Scholar
• Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018;68(1):55–63. doi:10.3322/caac.2143929092098
   PubMed Web of Science ®Google Scholar
• Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013;60(1):113–117. doi:10.1507/endocrj.ej12-031122972223
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng R, Su Y, et al. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: a single-center retrospective analysis of 3273 cases. Medicine. 2017;96(43):e8365. doi:10.1097/MD.000000000000836529069024
   PubMed Web of Science ®Google Scholar
• Xue S, Wang P, Liu J, Li R, Zhang L, Chen G. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: a retrospective study in China. Asian J Surg. 2016;39(3):131–136. doi:10.1016/j.asjsur.2015.03.01526117203
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang Z, Meng X, Duh QY, Chen G. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): a retrospective analysis of 1304 cases. Asian J Surg. 2019;42(4):571–576. doi:10.1016/j.asjsur.2018.08.01330348606
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhang YM, Sun S, et al. Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma. J Huazhong Univ Sci Technolog Med Sci. 2016;36(6):823–827. doi:10.1007/s11596-016-1669-527924514
   PubMedGoogle Scholar
• Liang K, He L, Dong W, Zhang H. Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: a study of 529 patients. Med Sci Mon. 2014;20:807–811. doi:10.12659/MSM.890182
   PubMed Web of Science ®Google Scholar
• Yao X, Meng Y, Guo R, et al. Value of ultrasound combined with immunohistochemistry evaluation of central lymph node metastasis for the prognosis of papillary thyroid carcinoma. Cancer Manag Res. 2020;12:8787–8799. doi:10.2147/CMAR.S26575633061575
   PubMed Web of Science ®Google Scholar
• Sakorafas GH, Stafyla V, Kolettis T, Tolumis G, Kassaras G, Peros G. Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease. J Postgrad Med. 2007;53(1):23–26. doi:10.4103/0022-3859.3032317244966
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng R, Ma Y, et al. Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma. Sci Rep. 2018;8(1):6962. doi:10.1038/s41598-018-24668-629725017
   PubMed Web of Science ®Google Scholar
• Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30(1):91–99. doi:10.1007/s00268-005-0113-y16369721
   PubMed Web of Science ®Google Scholar
• Jeon MJ, Kim WG, Choi YM, et al. Features predictive of distant metastasis in papillary thyroid microcarcinomas. Thyroid. 2016;26(1):161–168. doi:10.1089/thy.2015.037526563473
   PubMed Web of Science ®Google Scholar
• Ha J, Lee J, Jo K, et al. Calcification patterns in papillary thyroid carcinoma are associated with changes in thyroid hormones and coronary artery calcification. J Clin Med. 2018;7:8. doi:10.3390/jcm7080183
   Web of Science ®Google Scholar
• Oh EM, Chung YS, Song WJ, Lee YD. The pattern and significance of the calcifications of papillary thyroid microcarcinoma presented in preoperative neck ultrasonography. Ann Surg Treat Res. 2014;86(3):115–121. doi:10.4174/astr.2014.86.3.11524761419
   PubMed Web of Science ®Google Scholar
• Guerlain J, Perie S, Lefevre M, et al. Localization and characterization of thyroid microcalcifications: a histopathological study. PLoS One. 2019;14(10):e0224138. doi:10.1371/journal.pone.022413831648281
   PubMed Web of Science ®Google Scholar